doi: 10.3389/fimmu.2023.1148209 Received 19 January 2023 Accepted 26 April 2023 Published 17 May 2023 Volume 14 - 2023 Edited by Christoph Thiemermann, Queen Mary University of London, United Kingdom Reviewed by Marcin Filip Osuchowski, Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Austria
Rated 5 out of 5 CHRISTINA GORDON Superb quality, efficient delivery, very little hassle, especially with refills
Tiwari S, Singh A, Gupta P, Amrutha K, Singh S
Stomach Paralysis The FDA has received reports of certain patients using semaglutide, encountering severe gastroparesis, commonly referred toas stomach paralysis. This condition leads to a significant slowing down of food digestion, potentially resulting in intense vomiting and nausea